Clinical trials
Ascites trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 9 |
| Recruiting | 4 |
| Terminated | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 3 |
| Suspended | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Michigan | 4 |
| NovaShunt AG | 2 |
| Sequana Medical N.V. | 2 |
| Air Force Military Medical University, China | 1 |
| Boston Medical Center | 1 |
| C. R. Bard | 1 |
| Changi General Hospital | 1 |
| Dana-Farber Cancer Institute | 1 |
| Edward Via Virginia College of Osteopathic Medicine | 1 |
| Gdynia Oncology Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascites | 52 |
| Fibrosis | 18 |
| Liver Cirrhosis | 13 |
| Hypertension, Portal | 8 |
| Liver Diseases | 7 |
| Hepatic Encephalopathy | 5 |
| End Stage Liver Disease | 3 |
| Pleural Effusion | 3 |
| Heart Failure | 2 |
| Hepatorenal Syndrome | 2 |
Trials
Showing 26 to 50 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.